TreeWAS – Variant ID: rs10967586

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C15.9 Oesophagus, unspecified	0.000	0.943	0.057
R20.2 Paraesthesia of skin	0.000	0.945	0.055
C15 Malignant neoplasm of oesophagus	0.000	0.948	0.052
C15.5 Lower third of oesophagus	0.000	0.949	0.051
C15.4 Middle third of oesophagus	0.000	0.958	0.042
C15.8 Overlapping lesion of oesophagus	0.000	0.963	0.037
C15.3 Upper third of oesophagus	0.000	0.963	0.037
C15.2 Abdominal part of oesophagus	0.000	0.963	0.037
C15.1 Thoracic part of oesophagus	0.000	0.963	0.037
C15.0 Cervical part of oesophagus	0.000	0.963	0.037
T39.1 4-Aminophenol derivatives	0.000	0.966	0.034
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.969	0.031
R20 Disturbances of skin sensation	0.000	0.971	0.029
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.971	0.029
R20.8 Other and unspecified disturbances of skin sensation	0.000	0.976	0.024
R20.3 Hyperaesthesia	0.000	0.979	0.021
R20.1 Hypoaesthesia of skin	0.000	0.979	0.021
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.979	0.021
T39.4 Antirheumatics, not elsewhere classified	0.000	0.979	0.021
T39.2 Pyrazolone derivatives	0.000	0.979	0.021
R20.0 Anaesthesia of skin	0.000	0.980	0.020
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.982	0.018
T39.0 Salicylates	0.000	0.982	0.018
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.983	0.017
S02.40 Fracture of malar and maxillary bones (closed)	0.011	0.989	0.000
T84.1 Mechanical complication of internal fixation device of bones of limb	0.000	0.991	0.009
C77.1 Intrathoracic lymph nodes	0.000	0.991	0.009
B37.8 Candidiasis of other sites	0.000	0.992	0.008
J33.8 Other polyp of sinus	0.006	0.994	0.000
B34.9 Viral infection, unspecified	0.006	0.994	0.000
S02.4 Fracture of malar and maxillary bones	0.005	0.994	0.000
M23.21 Derangement of meniscus due to old tear or injury (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.005	0.995	0.000
N83.2 Other and unspecified ovarian cysts	0.000	0.995	0.005
C78.0 Secondary malignant neoplasm of lung	0.000	0.995	0.005
L05.9 Pilonidal cyst without abscess	0.000	0.995	0.005
J43.9 Emphysema, unspecified	0.000	0.995	0.005
C78.2 Secondary malignant neoplasm of pleura	0.000	0.995	0.005
H40.9 Glaucoma, unspecified	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.995	0.005
C78.7 Secondary malignant neoplasm of liver	0.000	0.995	0.005
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.004	0.996	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.996	0.004
S02.41 Fracture of malar and maxillary bones (open)	0.004	0.996	0.000
L05.0 Pilonidal cyst with abscess	0.000	0.996	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
Q38.7 Pharyngeal pouch	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
L05 Pilonidal cyst	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.996	0.004
N63 Unspecified lump in breast	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.003
T36 Poisoning by systemic antibiotics	0.000	0.996	0.003
E89.0 Postprocedural hypothyroidism	0.000	0.996	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.003
C77.2 Intra-abdominal lymph nodes	0.000	0.997	0.003
B34 Viral infection of unspecified site	0.003	0.997	0.000
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.000	0.997	0.003
Y95 Nosocomial condition	0.003	0.997	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.997	0.003
J03.9 Acute tonsillitis, unspecified	0.000	0.997	0.003
T84 Complications of internal orthopaedic prosthetic devices, implants and grafts	0.000	0.997	0.003
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
T84.3 Mechanical complication of other bone devices, implants and grafts	0.000	0.997	0.003
Z13.9 Special screening examination, unspecified	0.000	0.997	0.003
C77.9 Lymph node, unspecified	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
B34.4 Papovirus infection, unspecified	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.997	0.003
A40.3 Septicaemia due to Streptococcus pneumoniae	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
H40.5 Glaucoma secondary to other eye disorders	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
A40.8 Other streptococcal septicaemia	0.003	0.997	0.000
T84.4 Mechanical complication of other internal orthopaedic devices, imnplants and grafts	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
C77.8 Lymph nodes of multiple regions	0.000	0.997	0.003
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.4 Other laxatives	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.000	0.997	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
T36.6 Rifamycins	0.000	0.997	0.003
T36.5 Aminoglycosides	0.000	0.997	0.003
T36.4 Tetracyclines	0.000	0.997	0.003
T36.3 Macrolides	0.000	0.997	0.003
T36.2 Chloramphenicol group	0.000	0.997	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
A40 Streptococcal septicaemia	0.003	0.997	0.000
B34.3 Parvovirus infection, unspecified	0.003	0.997	0.000
B34.2 Coronavirus infection, unspecified	0.003	0.997	0.000
B34.1 Enterovirus infection, unspecified	0.003	0.997	0.000
B34.0 Adenovirus infection, unspecified	0.003	0.997	0.000
T84.9 Unspecified complication of internal orthopaedic prosthetic device, implant and graft	0.000	0.997	0.003
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.997	0.003
H40.8 Other glaucoma	0.003	0.997	0.000
H40 Glaucoma	0.003	0.997	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
G35 Multiple sclerosis	0.003	0.997	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.002
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.002
T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts	0.000	0.997	0.003
C15-C26 Malignant neoplasms of digestive organs	0.000	0.997	0.003
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.003	0.997	0.000
H40.4 Glaucoma secondary to eye inflammation	0.003	0.997	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.997	0.003
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	0.997	0.003
C21 Malignant neoplasm of anus and anal canal	0.000	0.998	0.002
C16 Malignant neoplasm of stomach	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
T84.2 Mechanical complication of internal fixation device of other bones	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
C77.4 Inguinal and lower limb lymph nodes	0.000	0.998	0.002
E89.3 Postprocedural hypopituitarism	0.000	0.998	0.002
A40.9 Streptococcal septicaemia, unspecified	0.002	0.998	0.000
C16.0 Cardia	0.000	0.998	0.002
N13.4 Hydroureter	0.002	0.998	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.002	0.998	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.998	0.002
C77.0 Lymph nodes of head, face and neck	0.000	0.998	0.002
A46 Erysipelas	0.002	0.998	0.000
M79.67 Pain in limb (Ankle and foot)	0.000	0.998	0.002
A40.2 Septicaemia due to streptococcus, group D	0.002	0.998	0.000
A40.1 Septicaemia due to streptococcus, group B	0.002	0.998	0.000
C21.0 Anus, unspecified	0.000	0.998	0.002
K21.0 Gastro-oesophageal reflux disease with oesophagitis	0.002	0.998	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.000	0.998	0.002
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.000	0.998	0.002
C21.1 Anal canal	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.998	0.002
H40.6 Glaucoma secondary to drugs	0.002	0.998	0.000
H40.3 Glaucoma secondary to eye trauma	0.002	0.998	0.000
B37.9 Candidiasis, unspecified	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
A40.0 Septicaemia due to streptococcus, group A	0.002	0.998	0.000
O81.4 Vacuum extractor delivery	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
C24.0 Extrahepatic bile duct	0.000	0.998	0.002
J43 Emphysema	0.000	0.998	0.002
Z08 Follow-up examination after treatment for malignant neoplasm	0.002	0.998	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.000	0.998	0.002
C23 Malignant neoplasm of gallbladder	0.000	0.998	0.002
B34.8 Other viral infections of unspecified site	0.002	0.998	0.000
R25.1 Tremor, unspecified	0.000	0.998	0.002
J33 Nasal polyp	0.002	0.998	0.000
B25-B34 Other viral diseases	0.002	0.998	0.000
C16.9 Stomach, unspecified	0.000	0.998	0.002
Z53.0 Procedure not carried out because of contraindication	0.000	0.998	0.002
C22.9 Liver, unspecified	0.000	0.998	0.002
C76 Malignant neoplasm of other and ill-defined sites	0.000	0.998	0.002
C16.8 Overlapping lesion of stomach	0.000	0.998	0.002
C16.6 Greater curvature of stomach, unspecified	0.000	0.998	0.002
C16.4 Pylorus	0.000	0.998	0.002
C16.2 Body of stomach	0.000	0.998	0.002
C16.1 Fundus of stomach	0.000	0.998	0.002
C21.2 Cloacogenic zone	0.000	0.998	0.002
Q23.1 Congenital insufficiency of aortic valve	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.002
T40.8 Lysergide [LSD]	0.000	0.998	0.002
T40.7 Cannabis (derivatives)	0.000	0.998	0.002
T40.5 Cocaine	0.000	0.998	0.002
T40.3 Methadone	0.000	0.998	0.002
T40.1 Heroin	0.000	0.998	0.002
T40.0 Opium	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
C25 Malignant neoplasm of pancreas	0.000	0.998	0.002
C16.5 Lesser curvature of stomach, unspecified	0.000	0.998	0.002
E89.2 Postprocedural hypoparathyroidism	0.000	0.998	0.002
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.998	0.002
S92.20 Fracture of other tarsal bone(s) (closed)	0.002	0.998	0.000
T42.1 Iminostilbenes	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
Z98.0 Intestinal bypass and anastomosis status	0.002	0.998	0.000
C16.3 Pyloric antrum	0.000	0.998	0.002
C25.9 Pancreas, unspecified	0.000	0.998	0.002
Q38.8 Other congenital malformations of pharynx	0.002	0.998	0.000
Q38.6 Other congenital malformations of mouth	0.002	0.998	0.000
Q38.5 Congenital malformations of palate, not elsewhere classified	0.002	0.998	0.000
Q38.4 Congenital malformations of salivary glands and ducts	0.002	0.998	0.000
Q38.3 Other congenital malformations of tongue	0.002	0.998	0.000
Q38.2 Macroglossia	0.002	0.998	0.000
Q38.1 Ankyloglossia	0.002	0.998	0.000
Q38.0 Congenital malformations of lips, not elsewhere classified	0.002	0.998	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.998	0.002
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.998	0.002
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.998	0.002
E89.5 Postprocedural testicular hypofunction	0.000	0.998	0.002
E89.4 Postprocedural ovarian failure	0.000	0.998	0.002
E89.1 Postprocedural hypoinsulinaemia	0.000	0.998	0.002
R77.9 Abnormality of plasma protein, unspecified	0.002	0.998	0.000
C22.0 Liver cell carcinoma	0.000	0.998	0.002
B37 Candidiasis	0.000	0.998	0.002
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.002	0.998	0.000
N13.6 Pyonephrosis	0.002	0.998	0.000
Z93.5 Cystostomy status	0.002	0.998	0.000
C24.9 Biliary tract, unspecified	0.000	0.998	0.002
C24.8 Overlapping lesion of biliary tract	0.000	0.998	0.002
C77.5 Intrapelvic lymph nodes	0.000	0.998	0.002
B25 Cytomegaloviral disease	0.002	0.998	0.000
M23.23 Derangement of meniscus due to old tear or injury (Medial collateral ligament or Other and unspecified medial meniscus)	0.002	0.998	0.000
C22.7 Other specified carcinomas of liver	0.000	0.998	0.002
C22.4 Other sarcomas of liver	0.000	0.998	0.002
C22.3 Angiosarcoma of liver	0.000	0.998	0.002
C22.2 Hepatoblastoma	0.000	0.998	0.002
N13 Obstructive and reflux uropathy	0.002	0.998	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.002	0.998	0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.002	0.998	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.000	0.998	0.002
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.002	0.998	0.000
N32.3 Diverticulum of bladder	0.002	0.998	0.000
Q23.0 Congenital stenosis of aortic valve	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
T42.0 Hydantoin derivatives	0.000	0.998	0.002
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.002	0.998	0.000
M25.78 Osteophyte (Other)	0.002	0.998	0.000
N83.1 Corpus luteum cyst	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.000	0.998	0.002
A30-A49 Other bacterial diseases	0.002	0.998	0.000
C26.9 Ill-defined sites within the digestive system	0.000	0.998	0.002
C26.8 Overlapping lesion of digestive system	0.000	0.998	0.002
C26.1 Spleen	0.000	0.998	0.002
J43.8 Other emphysema	0.000	0.998	0.002
J43.1 Panlobular emphysema	0.000	0.998	0.002
J43.0 MacLeod's syndrome	0.000	0.998	0.002
B27 Infectious mononucleosis	0.002	0.998	0.000
C80 Malignant neoplasm without specification of site	0.000	0.998	0.002
S02 Fracture of skull and facial bones	0.002	0.998	0.000
C24.1 Ampulla of Vater	0.000	0.998	0.002
N10-N16 Renal tubulo-interstitial diseases	0.002	0.998	0.000
B25.9 Cytomegaloviral disease, unspecified	0.002	0.998	0.000
J33.1 Polypoid sinus degeneration	0.002	0.998	0.000
J43.2 Centrilobular emphysema	0.000	0.998	0.002
K86.3 Pseudocyst of pancreas	0.000	0.998	0.002
B33 Other viral diseases, not elsewhere classified	0.002	0.998	0.000
B30 Viral conjunctivitis	0.002	0.998	0.000
B26 Mumps	0.002	0.998	0.000
R23 Other skin changes	0.000	0.998	0.002
C26.0 Intestinal tract, part unspecified	0.000	0.998	0.002
T40.2 Other opioids	0.000	0.998	0.002
C76.8 Overlapping lesion of other and ill-defined sites	0.000	0.998	0.002
C76.7 Other ill-defined sites	0.000	0.998	0.002
C76.5 Lower limb	0.000	0.998	0.002
C76.4 Upper limb	0.000	0.998	0.002
C76.3 Pelvis	0.000	0.998	0.002
C76.2 Abdomen	0.000	0.998	0.002
C76.1 Thorax	0.000	0.998	0.002
C76.0 Head, face and neck	0.000	0.998	0.002
E03.9 Hypothyroidism, unspecified	0.000	0.998	0.002
R74.8 Abnormal levels of other serum enzymes	0.002	0.998	0.000
S02.2 Fracture of nasal bones	0.002	0.998	0.000
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
C22.1 Intrahepatic bile duct carcinoma	0.000	0.998	0.002
C25.8 Overlapping lesion of pancreas	0.000	0.998	0.002
C25.7 Other parts of pancreas	0.000	0.998	0.002
C25.4 Endocrine pancreas	0.000	0.998	0.002
C25.3 Pancreatic duct	0.000	0.998	0.002
K63.9 Disease of intestine, unspecified	0.002	0.998	0.000
N83.7 Haematoma of broad ligament	0.000	0.998	0.002
N83.6 Haematosalpinx	0.000	0.998	0.002
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.000	0.998	0.002
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]	0.000	0.998	0.002
R77 Other abnormalities of plasma proteins	0.002	0.998	0.000
S02.20 Fracture of nasal bones (closed)	0.002	0.998	0.000
C25.1 Body of pancreas	0.000	0.998	0.002
M23.2 Derangement of meniscus due to old tear or injury	0.002	0.998	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.998	0.002
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.002	0.998	0.000
Z93.0 Tracheostomy status	0.002	0.998	0.000
A39 Meningococcal infection	0.002	0.998	0.000
C17 Malignant neoplasm of small intestine	0.001	0.998	0.001
B37.7 Candidal septicaemia	0.000	0.998	0.001
B37.6 Candidal endocarditis	0.000	0.998	0.001
B37.5 Candidal meningitis	0.000	0.998	0.001
B37.2 Candidiasis of skin and nail	0.000	0.998	0.001
B25.8 Other cytomegaloviral diseases	0.001	0.998	0.000
B25.2 Cytomegaloviral pancreatitis	0.001	0.998	0.000
B25.1 Cytomegaloviral hepatitis	0.001	0.998	0.000
B25.0 Cytomegaloviral pneumonitis	0.001	0.998	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.002	0.998	0.000
R23.3 Spontaneous ecchymoses	0.000	0.998	0.002
R77.1 Abnormality of globulin	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.000	0.998	0.001
Z93.1 Gastrostomy status	0.002	0.998	0.000
R79.9 Abnormal finding of blood chemistry, unspecified	0.002	0.998	0.000
S02.7 Multiple fractures involving skull and facial bones	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.002	0.998	0.000
M23.29 Derangement of meniscus due to old tear or injury (Unspecified ligament or Unspecified meniscus)	0.002	0.998	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.002	0.998	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.998	0.002
B27.9 Infectious mononucleosis, unspecified	0.001	0.998	0.000
C25.2 Tail of pancreas	0.000	0.998	0.001
A44 Bartonellosis	0.001	0.998	0.000
A43 Nocardiosis	0.001	0.998	0.000
A42 Actinomycosis	0.001	0.998	0.000
A37 Whooping cough	0.001	0.998	0.000
A36 Diphtheria	0.001	0.998	0.000
A32 Listeriosis	0.001	0.998	0.000
A31 Infection due to other mycobacteria	0.001	0.998	0.000
A30 Leprosy [Hansen's disease]	0.001	0.998	0.000
A38 Scarlet fever	0.001	0.998	0.000
A35 Other tetanus	0.001	0.998	0.000
A34 Obstetrical tetanus	0.001	0.998	0.000
A33 Tetanus neonatorum	0.001	0.998	0.000
I71 Aortic aneurysm and dissection	0.000	0.998	0.001
N15 Other renal tubulo-interstitial diseases	0.001	0.998	0.000
N11 Chronic tubulo-interstitial nephritis	0.002	0.998	0.000
A39.4 Meningococcaemia, unspecified	0.001	0.998	0.000
B27.8 Other infectious mononucleosis	0.001	0.998	0.000
B27.1 Cytomegaloviral mononucleosis	0.001	0.998	0.000
B27.0 Gammaherpesviral mononucleosis	0.001	0.998	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.002	0.998	0.000
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.998	0.001
O72.0 Third-stage haemorrhage	0.002	0.998	0.000
R23.2 Flushing	0.000	0.998	0.001
J03 Acute tonsillitis	0.000	0.998	0.001
C17.0 Duodenum	0.001	0.998	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.001	0.998	0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.001	0.998	0.000
B26.9 Mumps without complication	0.001	0.998	0.000
B26.8 Mumps with other complications	0.001	0.998	0.000
B26.3 Mumps pancreatitis	0.001	0.998	0.000
B26.2 Mumps encephalitis	0.001	0.998	0.000
B26.1 Mumps meningitis	0.001	0.998	0.000
B26.0 Mumps orchitis	0.001	0.998	0.000
B30.9 Viral conjunctivitis, unspecified	0.001	0.998	0.000
B30.8 Other viral conjunctivitis	0.001	0.998	0.000
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.001	0.998	0.000
B30.2 Viral pharyngoconjunctivitis	0.001	0.998	0.000
B30.1 Conjunctivitis due to adenovirus	0.001	0.998	0.000
B30.0 Keratoconjunctivitis due to adenovirus	0.001	0.998	0.000
B33.8 Other specified viral diseases	0.001	0.998	0.000
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.001	0.998	0.000
B33.3 Retrovirus infections, not elsewhere classified	0.001	0.998	0.000
B33.2 Viral carditis	0.001	0.998	0.000
B33.1 Ross River disease	0.001	0.998	0.000
B33.0 Epidemic myalgia	0.001	0.998	0.000
J33.0 Polyp of nasal cavity	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
A48 Other bacterial diseases, not elsewhere classified	0.001	0.998	0.000
S02.21 Fracture of nasal bones (open)	0.001	0.998	0.000
K86.1 Other chronic pancreatitis	0.000	0.998	0.002
S92.2 Fracture of other tarsal bone(s)	0.001	0.998	0.000
B37.4 Candidiasis of other urogenital sites	0.000	0.998	0.001
B37.1 Pulmonary candidiasis	0.000	0.998	0.001
O81.3 Other and unspecified forceps delivery	0.001	0.998	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.001	0.998	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.001	0.998	0.000
Q23.4 Hypoplastic left heart syndrome	0.001	0.998	0.000
Q23.3 Congenital mitral insufficiency	0.001	0.998	0.000
Q23.2 Congenital mitral stenosis	0.001	0.998	0.000
S02.1 Fracture of base of skull	0.001	0.998	0.000
R74 Abnormal serum enzyme levels	0.001	0.998	0.000
M23.27 Derangement of meniscus due to old tear or injury-Capsular	0.001	0.998	0.000
I86.4 Gastric varices	0.000	0.998	0.001
J33.9 Nasal polyp, unspecified	0.002	0.998	0.000
N11.1 Chronic obstructive pyelonephritis	0.001	0.998	0.000
R76.8 Other specified abnormal immunological findings in serum	0.001	0.998	0.000
R77.8 Other specified abnormalities of plasma proteins	0.001	0.998	0.000
R77.2 Abnormality of alphafetoprotein	0.001	0.998	0.000
R77.0 Abnormality of albumin	0.001	0.998	0.000
C17.8 Overlapping lesion of small intestine	0.001	0.998	0.001
C17.3 Meckel's diverticulum	0.001	0.998	0.001
C17.1 Jejunum	0.001	0.998	0.001
Q66.8 Other congenital deformities of feet	0.001	0.998	0.000
R23.0 Cyanosis	0.000	0.998	0.001
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system	0.001	0.998	0.000
S02.70 Multiple fractures involving skull and facial bones (closed)	0.001	0.999	0.000
A39.9 Meningococcal infection, unspecified	0.001	0.999	0.000
A39.8 Other meningococcal infections	0.001	0.999	0.000
A39.5 Meningococcal heart disease	0.001	0.999	0.000
A39.3 Chronic meningococcaemia	0.001	0.999	0.000
A39.2 Acute meningococcaemia	0.001	0.999	0.000
A39.1 Waterhouse-Friderichsen syndrome	0.001	0.999	0.000
A39.0 Meningococcal meningitis	0.001	0.999	0.000
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.000	0.999	0.001
S02.9 Fracture of skull and facial bones, part unspecified	0.001	0.999	0.000
S02.6 Fracture of mandible	0.001	0.999	0.000
O81 Single delivery by forceps and vacuum extractor	0.001	0.999	0.000
R72 Abnormality of white blood cells, not elsewhere classified	0.001	0.999	0.000
S02.30 Fracture of orbital floor (closed)	0.001	0.999	0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.001	0.999	0.000
O72.2 Delayed and secondary postpartum haemorrhage	0.001	0.999	0.000
R76 Other abnormal immunological findings in serum	0.001	0.999	0.000
S02.31 Fracture of orbital floor (open)	0.001	0.999	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.001	0.999	0.000
N15.9 Renal tubulo-interstitial disease, unspecified	0.001	0.999	0.000
N99.0 Postprocedural renal failure	0.000	0.999	0.001
S02.8 Fractures of other skull and facial bones	0.001	0.999	0.000
N10 Acute tubulo-interstitial nephritis	0.001	0.999	0.000
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.999	0.001
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.000	0.999	0.001
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.001	0.999	0.000
K51.9 Ulcerative colitis, unspecified	0.000	0.999	0.001
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.999	0.001
N15.8 Other specified renal tubulo-interstitial diseases	0.001	0.999	0.000
N15.1 Renal and perinephric abscess	0.001	0.999	0.000
N15.0 Balkan nephropathy	0.001	0.999	0.000
R76.0 Raised antibody titer	0.001	0.999	0.000
G35-G37 Demyelinating diseases of the central nervous system	0.001	0.999	0.000
A30.9 Leprosy, unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations